Evidence map›Paper›PMID 33129279›Full record

ArticleBMC medical genetics2020

Novel variants of ABCA4 in Han Chinese families with Stargardt disease.

Fang-Yuan Hu, Feng-Juan Gao, Jian-Kang Li, Ping Xu, Dan-Dan Wang, Sheng-Hai Zhang, Ji-Hong Wu

Open access · goldAbstract read
In one paragraph

Article in BMC medical genetics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 49% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Fang-Yuan HuEye Institute and Department of Ophthalmology, Eye & ENT Hospital, Fudan University, Shanghai, China.
Feng-Juan GaoEye Institute and Department of Ophthalmology, Eye & ENT Hospital, Fudan University, Shanghai, China.
Jian-Kang LiBGI-Shenzhen, Shenzhen, China.
Ping XuEye Institute and Department of Ophthalmology, Eye & ENT Hospital, Fudan University, Shanghai, China.
Dan-Dan WangEye Institute and Department of Ophthalmology, Eye & ENT Hospital, Fudan University, Shanghai, China.
Sheng-Hai ZhangEye Institute and Department of Ophthalmology, Eye & ENT Hospital, Fudan University, Shanghai, China.
Ji-Hong WuEye Institute and Department of Ophthalmology, Eye & ENT Hospital, Fudan University, Shanghai, China. jihongwu@fudan.edu.cn.ORCID 0000-0003-3892-5757
Chinese Academy of Medical Sciences & Peking Union Medical College · CNBGI Group (China) · CN

Funding

Aging and women's and children's health Special project of Shanghai Municipal Health Commission 2020YJZX0102National Natural Science Foundation of China NSFC81770925National Natural Science Foundation of China NSFC81790641Non-profit Central Research Institute Fund of Chinese Academy of Medical Sciences 2018PT32019Outstanding Academic Leaders in Shanghai 20XD1401100Program for Outstanding Medical Academic Leader 2019LJ01Xuhui District Health and Family Planning Commission Key Disease Joint Project XHLHGG201807
6 · The paper itself

Abstract

backgroundStargardt disease (STGD1) is a common recessive hereditary macular dystrophy in early adulthood or childhood, with an estimated prevalence of 1:8000 to 1:10,000. ABCA4 is the causative gene for STGD1. The current study aims at identifying the novel disease-related ABCA4 variants in Han Chinese families with STGD1 using next-generation sequencing (NGS).

methodsIn the present study, 12 unrelated Han Chinese families (19 males and 17 females) with STGD1 were tested by panel-based NGS. In order to capture the coding exons and the untranslated regions (UTRs) plus 30 bp of intronic flanking sequences of 792 genes, which were closely associated with usual ophthalmic genetic disease, we designed a customized panel, namely, Target_Eye_792_V2 chip. STGD1 patients were clinically diagnosed by experienced ophthalmologists. All the detected variants were filtered and analyzed through the public databases and in silico programs to assess potential pathogenicity.

resultsTwenty-one ABCA4 mutant variants were detected in 12 unrelated Han Chinese families with STGD1, containing 14 missense, three splicing, two frameshift, one small deletion, and one nonsense variants. Base on the American College of Medical Genetics (ACMG) guidelines, 8 likely pathogenic and 13 pathogenic variants were determined. The functional consequences of these mutant variants were predicted through in silico programs. Of the 21 mutant variants in ABCA4, two novel coding variants c.3017G > A and c.5167 T > C and one novel null variant c.3051-1G > A were detected in three unrelated probands.

conclusionsBy panel-based NGS, 21 ABCA4 variants were confirmed in 12 unrelated Han Chinese families. Among them, 3 novel mutant variants were found, which further expanded the ABCA4 mutation spectrum in STGD1 patients.

Indexed as

MutationAdolescentAdultAmino Acid SequenceAnimalsAsian PeopleATP-Binding Cassette TransportersChildExonsFamilyFemaleGene ExpressionHigh-Throughput Nucleotide SequencingHumansIntronsMaleABCA4 protein, humanATP-Binding Cassette TransportersABCA4 geneHan Chinese patientsNovel mutant variantsPanel-based NGSSTGD1

Identifiers

PMID33129279
PMCPMC7602306
OpenAlexW3097839276

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.